Mechanism of estrogen-mediated attenuation of hepatic injury following trauma-hemorrhage: Akt-dependent HO-1 up-regulation

J Leukoc Biol. 2007 Oct;82(4):1019-26. doi: 10.1189/jlb.0607355. Epub 2007 Jul 26.

Abstract

Protein kinase B (Akt) is known to be involved in proinflammatory and chemotactic events in response to injury. Akt activation also leads to the induction of heme oxygenase (HO)-1. Up-regulation of HO-1 mediates potent, anti-inflammatory effects and attenuates organ injury. Although studies have shown that 17beta-estradiol (E2) prevents organ damage following trauma-hemorrhage, it remains unknown whether Akt/HO-1 plays any role in E2-mediated attenuation of hepatic injury following trauma-hemorrhage. To study this, male rats underwent trauma-hemorrhage (mean blood pressure, approximately 40 mmHg for 90 min), followed by fluid resuscitation. At the onset of resuscitation, rats were treated with vehicle, E2 (1 mg/kg body weight), E2 plus the PI-3K inhibitor (Wortmannin), or the estrogen receptor (ER) antagonist (ICI 182,780). At 2 h after sham operation or trauma-hemorrhage, plasma alpha-GST and hepatic tissue myeloperoxidase (MPO) activity, IL-6, TNF-alpha, ICAM-1, cytokine-induced neutrophil chemoattractant-1, and MIP-2 levels were measured. Hepatic Akt and HO-1 protein levels were also determined. Trauma-hemorrhage increased hepatic injury markers (alpha-GST and MPO activity), cytokines, ICAM-1, and chemokine levels. These parameters were markedly improved in the E2-treated rats following trauma-hemorrhage. E2 treatment also increased hepatic Akt activation and HO-1 expression compared with vehicle-treated, trauma-hemorrhage rats, which were abolished by coadministration of Wortmannin or ICI 182,780. These results suggest that the salutary effects of E2 on hepatic injury following trauma-hemorrhage are in part mediated via an ER-related, Akt-dependent up-regulation of HO-1.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Androstadienes / pharmacology
  • Animals
  • Blood Pressure / drug effects
  • Chemokine CXCL1 / biosynthesis
  • Chemokine CXCL2 / biosynthesis
  • Estradiol / analogs & derivatives
  • Estradiol / pharmacology*
  • Estrogen Antagonists / pharmacology
  • Estrogens / pharmacology
  • Fulvestrant
  • Gene Expression Regulation, Enzymologic / drug effects*
  • Glutathione Transferase / metabolism
  • Heme Oxygenase-1 / biosynthesis*
  • Hemorrhage / enzymology*
  • Hemorrhage / pathology
  • Intercellular Adhesion Molecule-1 / biosynthesis
  • Interleukin-6 / biosynthesis
  • Liver / enzymology*
  • Liver / injuries*
  • Liver / pathology
  • Male
  • Peroxidase / biosynthesis
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Estrogen / metabolism
  • Resuscitation
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Up-Regulation / drug effects
  • Wortmannin
  • Wounds and Injuries / enzymology*
  • Wounds and Injuries / pathology

Substances

  • Androstadienes
  • Chemokine CXCL1
  • Chemokine CXCL2
  • Cxcl1 protein, rat
  • Cxcl2 protein, rat
  • Estrogen Antagonists
  • Estrogens
  • Interleukin-6
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors
  • Receptors, Estrogen
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1
  • Fulvestrant
  • Estradiol
  • Peroxidase
  • Heme Oxygenase-1
  • Glutathione Transferase
  • Proto-Oncogene Proteins c-akt
  • Wortmannin